ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
iTeos Therapeutics Inc

iTeos Therapeutics Inc (ITOS)

7.265
-0.055
( -0.75% )
업데이트: 01:45:11

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
7.265
매수가
7.26
매도가
7.27
거래량
96,897
7.17 일간 변동폭 7.30
7.09 52주 범위 18.75
market_cap
전일 종가
7.32
개장가
7.26
최근 거래 시간
2
@
7.265
마지막 거래 시간
01:45:36
재정 규모
US$ 701,143
VWAP
7.236
평균 볼륨(3m)
566,343
발행 주식
36,533,918
배당수익률
-
주가수익률
-2.35
주당순이익(EPS)
-3.08
매출
12.6M
순이익
-112.64M

iTeos Therapeutics Inc 정보

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
본부
Wilmington, Delaware, USA
설립됨
-
iTeos Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker ITOS. The last closing price for iTeos Therapeutics was US$7.32. Over the last year, iTeos Therapeutics shares have traded in a share price range of US$ 7.09 to US$ 18.75.

iTeos Therapeutics currently has 36,533,918 shares in issue. The market capitalisation of iTeos Therapeutics is US$267.43 million. iTeos Therapeutics has a price to earnings ratio (PE ratio) of -2.35.

ITOS 최신 뉴스

iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress

- Inupadenant + carboplatin/pemetrexed in Phase 2 A2A-005 trial demonstrated a 63.9% overall response rate (ORR) and a median PFS of 7.7 months for all evaluable patients across the cohorts...

iTeos to Participate in Upcoming Investor Conferences

WATERTOWN, Mass. and GOSSELIES, Belgium, Nov. 26, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and...

iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates

- EMA granted clearance to advance belrestotug 400mg + dostarlimab as recommended Phase 3 dose and activate GALAXIES Lung-301 clinical sites in the EU- Interim data from inupadenant Phase 2...

iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress

WATERTOWN, Mass. and GOSSELIES, Belgium, Oct. 24, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.115-1.558265582667.387.537.173185067.37134313CS
4-1.145-13.6147443528.418.737.095110197.75881781CS
12-2.765-27.567298105710.0310.227.095663438.57040649CS
26-7.565-51.011463250214.8318.137.0952835111.24805639CS
52-3.655-33.470695970710.9218.757.0944422212.23422699CS
156-38.695-84.192776327245.9652.437.0941037617.79222125CS
260-12.435-63.121827411219.752.437.0936168020.39929701CS

ITOS - Frequently Asked Questions (FAQ)

What is the current iTeos Therapeutics share price?
The current share price of iTeos Therapeutics is US$ 7.265
How many iTeos Therapeutics shares are in issue?
iTeos Therapeutics has 36,533,918 shares in issue
What is the market cap of iTeos Therapeutics?
The market capitalisation of iTeos Therapeutics is USD 267.43M
What is the 1 year trading range for iTeos Therapeutics share price?
iTeos Therapeutics has traded in the range of US$ 7.09 to US$ 18.75 during the past year
What is the PE ratio of iTeos Therapeutics?
The price to earnings ratio of iTeos Therapeutics is -2.35
What is the cash to sales ratio of iTeos Therapeutics?
The cash to sales ratio of iTeos Therapeutics is 21.06
What is the reporting currency for iTeos Therapeutics?
iTeos Therapeutics reports financial results in USD
What is the latest annual turnover for iTeos Therapeutics?
The latest annual turnover of iTeos Therapeutics is USD 12.6M
What is the latest annual profit for iTeos Therapeutics?
The latest annual profit of iTeos Therapeutics is USD -112.64M
What is the registered address of iTeos Therapeutics?
The registered address for iTeos Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the iTeos Therapeutics website address?
The website address for iTeos Therapeutics is www.iteostherapeutics.com
Which industry sector does iTeos Therapeutics operate in?
iTeos Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NXUNXU Inc
US$ 1.4516
(496.38%)
359.04M
WATTEnergous Corporation
US$ 1.5806
(284.39%)
157.58M
INTZIntrusion Inc
US$ 5.68
(162.96%)
107.97M
CYNCYNGN Inc
US$ 1.299
(106.88%)
55.86M
HOLOMicroCloud Hologram Inc
US$ 4.31
(79.58%)
84.35M
ABPAbpro Holdings Inc
US$ 2.02
(-55.01%)
1.23M
TRAWTraws Pharma Inc
US$ 7.75
(-42.25%)
834.64k
LITMSnow Lake Resources Ltd
US$ 1.13
(-29.38%)
42.42M
LGHLWLion Group Holding Ltd
US$ 0.0052
(-25.71%)
54.71k
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 66.5854
(-24.73%)
7.5k
NXUNXU Inc
US$ 1.4591
(499.47%)
359.09M
VINCVincerx Inc
US$ 0.3497
(80.26%)
286.42M
XTIAXTI Aerospace Inc
US$ 0.03995
(1.14%)
163.36M
WATTEnergous Corporation
US$ 1.5883
(286.26%)
157.58M
INTZIntrusion Inc
US$ 5.675
(162.73%)
107.98M

ITOS Discussion

게시물 보기
Monksdream Monksdream 1 주 전
ITOS, under $8
👍️0
Monksdream Monksdream 2 월 전
ITOS under $10
👍️0
Monksdream Monksdream 4 월 전
ITOS needs to break $19
👍️0
Awl416 Awl416 8 월 전
iTeos Therapeutics Announces $120 Million Registered Direct Offering
👍️0
TonyJoe1957 TonyJoe1957 3 년 전
$14.41 EPS estimate for 3rd quarter posted today on TDAmeritrade.
👍️0
TonyJoe1957 TonyJoe1957 3 년 전
https://seekingalpha.com/article/4449555-iteos-therapeutics-my-calculations-suggest-q3-earnings-will-exceed-10-per-share
👍️0
TonyJoe1957 TonyJoe1957 3 년 전
Wow!
No one posting or interested in this stock?
👍️0
TonyJoe1957 TonyJoe1957 4 년 전
Note the intraday lows for the past 3 trading days. Program trading walking it down to $25.60, $25.30 and $25.25. Stay well. AJ
👍️0
TonyJoe1957 TonyJoe1957 4 년 전
I think we are trading below cash per share.
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 년 전
ITOS $28.50 gonna be wild in little after $30
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 년 전
Itos will break $30 and game on,holding here
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 년 전
ITOS~~$28.11
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 년 전
ITOS~~MA200,@ $28.75,should break today here
👍️0
TonyJoe1957 TonyJoe1957 4 년 전
Bought 580 sh, so far.
5 analysts at 8:30A webcast.
All congratulated the firm on the deal.
I anticipate an easy double in the next few months with upgrades.
Look at the balance sheet.
Really, really big cash infusion.
AJ
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 년 전
ITOS~~bought 809 shares @$33pm,little high on spike ,but should go nicely up,crazy huge news
👍️0
$treet $inatra $treet $inatra 4 년 전
https://investors.iteostherapeutics.com/news-and-events/press-releases


👍️0